Regulatory News Roundup: Two Customs Strikes Against MyNicNaxs, U.K. Ad Enforcement
This article was originally published in The Tan Sheet
Executive Summary
Two Customs strikes against MyNicNaxs; drug claims and GMP problems; curcumin bioavailability claim nixed; and U.K. ad enforcement news.
You may also be interested in...
NDI Notification Estimate Unchanged: Health And Wellness Industry News
Biotek gets FDA's own-labeler lesson; MyNicNaxs shut down after ignoring warning; and FDA sticks with NDI notification cost estimate.
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.